The new company (mentioned earlier) has a 3 year supply of Urokinase that they got when they bought the original company (in a merger/acquisition). They do not have approval to sell in the US as it is a Canadian company, so they are going through the FDA to get approval. Then once they get approval they will need another finacial partner to be able to manufacture it. So, that 3 year supply is about all we have at the moment and could be the end of Urokinase once depleated.
